Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02156986 · ClinicalTrials.gov registry record
Chewing Capability Study for Infants and Toddlers
A clinical trial, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 68
- Enrollment target
NCT02156986: Completed study, sponsored by Société des Produits Nestlé (SPN).
NCT02156986 is a clinical trial that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02156986 has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The main objective of the study is to conduct a pilot study on the characterization of the mastication abilities of infants and toddlers using different commercial cereal based products in order to gain knowledge and be able to plan future studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-07 |
What the finished NCT02156986 record still lists
NCT02156986 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02156986 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02156986 about?
NCT02156986 is a clinical study titled "Chewing Capability Study for Infants and Toddlers". The main objective of the study is to conduct a pilot study on the characterization of the mastication abilities of infants and toddlers using different commercial cereal based products in order to gain knowledge and be able to plan future studies.
What is the current status of trial NCT02156986?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2013-10. Estimated completion is 2014-07.
Who is sponsoring clinical trial NCT02156986?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia